Cholinergic signaling in Alzheimer disease : therapeutic strategiesPERRY, Elaine.Alzheimer disease and associated disorders. 1995, Vol 9, issn 0893-0341, 67 p., SUP2Serial Issue

Dreaming and hallucinations - Continuity or discontinuity? Perspectives from dementia with Lewy bodiesCOLLERTON, Daniel; PERRY, Elaine.Consciousness and cognition (Print). 2011, Vol 20, Num 4, pp 1016-1020, issn 1053-8100, 5 p.Conference Paper

Nonclassical roles of cholinesterases in the embryonic brain and possible links to Alzheimer diseaseLAYER, P. G.Alzheimer disease and associated disorders. 1995, Vol 9, pp 29-36, issn 0893-0341, SUP2Article

Aromatherapy in the management of psychiatric disorders : Clinical and neuropharmacological perspectivesPERRY, Nicolette; PERRY, Elaine.CNS drugs. 2006, Vol 20, Num 4, pp 257-280, issn 1172-7047, 24 p.Article

The Role of Phytochemicals in the Treatment and Prevention of DementiaHOWES, Melanie-Jayne R; PERRY, Elaine.Drugs & aging. 2011, Vol 28, Num 6, pp 439-468, issn 1170-229X, 30 p.Article

Distribution of nicotinic subtypes in human brainCOURT, J; CLEMENTI, F.Alzheimer disease and associated disorders. 1995, Vol 9, pp 6-14, issn 0893-0341, SUP2Article

Signal transduction mechanisms in Alzheimer diseaseSHUN SHIMOHAMA; MATSUSHIMA, H.Alzheimer disease and associated disorders. 1995, Vol 9, pp 15-22, issn 0893-0341, SUP2Article

Alzheimer disease, attention, and the cholinergic systemLAWRENCE, A. D; SAHAKIAN, B. J.Alzheimer disease and associated disorders. 1995, Vol 9, pp 43-49, issn 0893-0341, SUP2Article

Why people see things that are not there : A novel Perception and Attention Deficit model for recurrent complex visual hallucinationsCOLLERTON, Daniel; PERRY, Elaine; MCKEITH, Ian et al.Behavioral and brain sciences (Print). 2005, Vol 28, Num 6, pp 737-794, issn 0140-525X, 58 p.Article

Cholinesterases and the pathology of Alzheimer diseaseCHANGIZ GEULA; MESULAM, M.-M.Alzheimer disease and associated disorders. 1995, Vol 9, pp 23-28, issn 0893-0341, SUP2Article

Nicotinic receptors and neurodegenerative dementing diseases : basic research and clinical implicationsWHITEHOUSE, P. J; KALARIA, R. N.Alzheimer disease and associated disorders. 1995, Vol 9, pp 3-5, issn 0893-0341, SUP2Article

Medicinal Plants and Dementia Therapy: Herbal Hopes for Brain Aging?PERRY, Elaine; HOWES, Melanie-Jayne R.CNS neuroscience & therapeutics (Print). 2011, Vol 17, Num 6, pp 683-698, issn 1755-5930, 16 p.Article

Clinical heterogeneity : responders to cholinergic therapyEAGGER, S. A; HARVEY, R. J.Alzheimer disease and associated disorders. 1995, Vol 9, pp 37-42, issn 0893-0341, SUP2Article

Consciousness without a cerebral cortex: A challenge for neuroscience and medicine. Commentaries. Author's replyMERKER, Bjorn; ABOITIZ, Francisco; COENEN, Anton M. L et al.Behavioral and brain sciences (Print). 2007, Vol 30, Num 1, pp 63-134, issn 0140-525X, 72 p.Article

A Double-Blind Placebo-Controlled Randomized Trial of Melissa officinalis Oil and Donepezil for the Treatment of Agitation in Alzheimer's DiseaseBURNS, Alistair; PERRY, Elaine; HOLMES, Clive et al.Dementia and geriatric cognitive disorders. 2011, Vol 31, Num 2, pp 158-164, issn 1420-8008, 7 p.Article

Parkinson Disease With Dementia: Comparing Patients With and Without Alzheimer PathologySABBAGH, Marwan N; ADLER, Charles H; PERRY, Elaine et al.Alzheimer disease and associated disorders. 2009, Vol 23, Num 3, pp 295-297, issn 0893-0341, 3 p.Article

Hallucinations predict attentional improvements with rivastigmine in dementia with Lewy bodiesMCKEITH, Ian G; WESNES, Keith A; PERRY, Elaine et al.Dementia and geriatric cognitive disorders. 2004, Vol 18, Num 1, pp 94-100, issn 1420-8008, 7 p.Article

A positive association between 5HT re-uptake binding sites and depression in dementia with Lewy bodiesBALLARD, Clive; JOHNSON, Mary; PIGGOTT, Margaret et al.Journal of affective disorders. 2002, Vol 69, Num 1-3, pp 219-223, issn 0165-0327Article

Nicotinic receptor abnormalities in Alzheimer's disease : Nicotine mechanisms in Alzheimer's diseaseCOURT, Jennifer; MARTIN-RUIZ, Carmen; PIGGOTT, Margaret et al.Biological psychiatry (1969). 2001, Vol 49, Num 3, pp 175-184, issn 0006-3223Article

Nicotinic receptor subtypes in human brain related to aging and dementiaPERRY, Elaine K; MARTIN-RUIZ, Carmen M; COURT, Jennifer A et al.Alcohol (Fayetteville, NY). 2001, Vol 24, Num 2, pp 63-68, issn 0741-8329Conference Paper

In vitro anti-β-secretase and dual anti-cholinesterase activities of Camellia sinensis L. (tea) relevant to treatment of dementiaOKELLO, Edward J; SAVELEV, Sergev U; PERRY, Elaine K et al.PTR. Phytotherapy research. 2004, Vol 18, Num 8, pp 624-627, issn 0951-418X, 4 p.Article

Butyryl- and acetyl-cholinesterase inhibitory activities in essential oils of Salvia species and their constituentsSAVELEV, Sergey U; OKELLO, Edward J; PERRY, Elaine K et al.PTR. Phytotherapy research. 2004, Vol 18, Num 4, pp 315-324, issn 0951-418X, 10 p.Article

Butyrylcholinesterase and progression of cognitive deficits in dementia with Lewy bodiesPERRY, Elaine; MCKEITH, Ian; BALLARD, Clive et al.Neurology. 2003, Vol 60, Num 11, pp 1852-1853, issn 0028-3878, 2 p.Article

Altered neurogenesis in Alzheimer's diseaseZIABREVA, Iryna; PERRY, Elaine; PERRY, Robert et al.Journal of psychosomatic research. 2006, Vol 61, Num 3, pp 311-316, issn 0022-3999, 6 p.Article

Potential treatment of Alzheimer disease using cholinergic channel activators (ChCAs) with cognitive enhancement, anxiolytic-like, and cytoprotetive propertiesARNERIC, S. P; SULLIVAN, J. P; WILLIAMS, M et al.Alzheimer disease and associated disorders. 1995, Vol 9, pp 50-61, issn 0893-0341, SUP2Article